News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
406,924 Results
Type
Article (26924)
Company Profile (41)
Press Release (379953)
Multimedia
Podcasts (43)
Webinars (7)
Section
Business (119754)
Career Advice (459)
Deals (17161)
Drug Delivery (67)
Drug Development (48132)
Employer Resources (48)
FDA (12517)
Job Trends (8683)
News (189086)
Policy (20170)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1797)
Accelerated approval (31)
ADA (31)
Adcomms (12)
Allergies (154)
Alliances (27139)
ALS (135)
Alzheimer's disease (1113)
Antibody-drug conjugate (ADC) (308)
Approvals (13099)
Artificial intelligence (438)
ASCO (206)
Autoimmune disease (213)
Automation (14)
Bankruptcy (153)
Best Places to Work (7047)
BIO (28)
BIOSECURE Act (5)
Biosimilars (118)
BioSpace Insights (66)
Biotechnology (29)
Bladder cancer (169)
Brain cancer (48)
Breast cancer (541)
Cancer (4208)
Cardiovascular disease (351)
Career advice (421)
Career pathing (17)
CAR-T (171)
CDC (36)
Celiac Disease (3)
Cell therapy (479)
Cervical cancer (42)
Clinical research (44751)
Collaboration (1173)
Commercialization (5)
Company closure (1)
Compensation (343)
Complete response letters (33)
COVID-19 (1602)
CRISPR (51)
C-suite (785)
Cystic fibrosis (69)
Data (6093)
Decentralized trials (2)
Denatured (23)
Depression (129)
Dermatology (85)
Diabetes (443)
Diagnostics (4031)
Digital health (46)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (140)
Drug pricing (156)
Drug shortages (24)
Duchenne muscular dystrophy (159)
Earnings (40590)
Editorial (40)
Employer branding (6)
Employer resources (49)
Events (56738)
Executive appointments (717)
FDA (15684)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (11)
Frontotemporal dementia (16)
Funding (996)
Gene editing (104)
Generative AI (27)
Gene therapy (357)
GLP-1 (652)
Government (3312)
Grass and pollen (4)
Guidances (277)
Healthcare (12604)
Hematology (128)
HIV (64)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (66)
Immunology and inflammation (101)
Immuno-oncology (59)
Indications (166)
Infectious disease (1801)
Inflammatory bowel disease (143)
Inflation Reduction Act (12)
Influenza (71)
Intellectual property (162)
Interviews (41)
IPO (7200)
IRA (40)
Job creations (1876)
Job search strategy (383)
JPM (19)
Kidney cancer (18)
Labor market (51)
Layoffs (215)
Leadership (11)
Legal (3914)
Licensing (2)
Liver cancer (75)
Longevity (12)
Lung cancer (651)
Lymphoma (346)
Machine learning (29)
Management (19)
Manufacturing (452)
Marketing (3)
MASH (139)
Medical affairs (1)
Medical device (13619)
Medtech (13824)
Mergers & acquisitions (10649)
Metabolic disorders (1042)
mRNA (94)
Multiple sclerosis (131)
NASH (12)
Neurodegenerative disease (242)
Neuropsychiatric disorders (59)
Neuroscience (2123)
NextGen: Class of 2026 (4025)
Non-profit (2972)
Now hiring (43)
Obesity (426)
Opinion (126)
Ovarian cancer (180)
Pain (203)
Pancreatic cancer (224)
Parkinson's disease (233)
Partnered (19)
Patents (321)
Patient recruitment (618)
Peanut (51)
People (36805)
Pharmaceutical (14)
Pharmacy benefit managers (21)
Phase 1 (12829)
Phase 2 (19387)
Phase 3 (15904)
Pipeline (6633)
Policy (181)
Postmarket research (1682)
Preclinical (3950)
Press Release (18)
Prostate cancer (258)
Psychedelics (31)
Radiopharmaceuticals (233)
Rare diseases (666)
Real estate (2901)
Recruiting (20)
Regulatory (17136)
Reports (20)
Research institute (1706)
Resumes & cover letters (50)
Rett syndrome (26)
RNA editing (9)
RSV (51)
Schizophrenia (149)
Series A (161)
Series B (116)
Service/supplier (2)
Sickle cell disease (71)
Special edition (8)
Spinal muscular atrophy (109)
Sponsored (17)
Startups (2157)
Stomach cancer (11)
Supply chain (77)
Tariffs (38)
The Weekly (20)
Vaccines (596)
Venture capital (38)
Weight loss (283)
Women's health (93)
Worklife (4)
Date
Today (22)
Last 7 days (311)
Last 30 days (1036)
Last 365 days (16521)
2026 (9821)
2025 (16646)
2024 (20022)
2023 (22938)
2022 (30892)
2021 (33240)
2020 (32557)
2019 (28911)
2018 (22256)
2017 (19103)
2016 (18353)
2015 (21402)
2014 (16189)
2013 (13404)
2012 (14517)
2011 (14833)
2010 (13378)
Location
Africa (382)
Alabama (34)
Alaska (2)
Arizona (249)
Arkansas (12)
Asia (26353)
Australia (4167)
California (7216)
Canada (2343)
China (1136)
Colorado (374)
Connecticut (382)
Delaware (321)
Europe (51860)
Florida (1221)
Georgia (304)
Hawaii (2)
Idaho (35)
Illinois (821)
India (45)
Indiana (487)
Iowa (12)
Japan (472)
Kansas (102)
Kentucky (32)
Louisiana (44)
Maine (30)
Maryland (1059)
Massachusetts (4824)
Michigan (190)
Minnesota (587)
Mississippi (6)
Missouri (104)
Montana (21)
Nebraska (23)
Nevada (85)
New Hampshire (79)
New Jersey (2500)
New Mexico (11)
New York (2122)
North Carolina (1005)
North Dakota (4)
Northern California (3535)
Ohio (272)
Oklahoma (11)
Oregon (27)
Pennsylvania (1672)
Puerto Rico (17)
Rhode Island (39)
South America (553)
South Carolina (80)
Southern California (2989)
Tennessee (171)
Texas (1385)
United States (27951)
Utah (252)
Virginia (193)
Washington D.C. (53)
Washington State (518)
West Virginia (4)
Wisconsin (91)
Wyoming (1)
406,924 Results for "magenta medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Magenta Medical Completes Enrollment to Early Feasibility Study for World’s Smallest Heart Pump
Magenta Medical, developer of the world’s smallest heart pump, announced the completion of enrollment to its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device for the high-risk percutaneous coronary intervention indication.
August 22, 2023
·
4 min read
Magenta Medical Closes $55M Funding Round Led by OrbiMed
Magenta Medical, developer of the world’s smallest heart pump, announced a $55M financing round led by global healthcare investment manager OrbiMed, with participation from existing investors New Enterprise Associates, Pitango VC, and ALIVE - Israel HealthTech Fund.
May 3, 2023
·
5 min read
Biotech Bay
Magenta Medical Reports Positive Results for US Early Feasibility Study of Elevate™ Heart Pump in Providing Temporary Mechanical Circulatory Support During High-Risk PCI Procedures
The US Early Feasibility Study of Magenta Medical’s Elevate™ System, designed to provide temporary mechanical circulatory support during high-risk percutaneous coronary intervention (HR-PCI) procedures, has successfully met its objectives.
October 26, 2023
·
4 min read
Results from Magenta Medical’s US Early Feasibility Study of the World’s Smallest and Most Powerful Heart Pump to be Highlighted at TCT 2023
Results from Magenta Medical’s Early Feasibility Study of the Elevate™ System, for the high-risk percutaneous coronary intervention (HR-PCI) indication, will be announced in an oral presentation at the Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation in San Francisco. Elevate™ is the world’s smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).
October 10, 2023
·
3 min read
Press Releases
Medical Care Technologies (OTC PINK:MDCE) Advances Rigorous Multi-Phase Validation of AI Imaging Platform
July 23, 2026
·
2 min read
Biotech Bay
Magenta Medical Reports Positive Results for US Early Feasibility Study of Elevate™ Heart Pump in Providing Temporary Mechanical Circulatory Support During High-Risk PCI Procedures Results presented at TCT 2023 in San Francisco
The US Early Feasibility Study of Magenta Medical’s Elevate™ System, designed to provide temporary mechanical circulatory support during high-risk percutaneous coronary intervention (HR-PCI) procedures, has successfully met its objectives. Elevate™ is the smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD) in the world.
October 25, 2023
·
4 min read
Deals
Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement
Magenta Therapeutics, Inc. (Nasdaq: MGTA) (“Magenta”) and Dianthus Therapeutics, Inc. (“Dianthus”), a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, announced today that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.
May 3, 2023
·
16 min read
Press Releases
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Integration into McKesson’s Medical-Surgical Solutions marketplace serving a nationwide customer base
June 30, 2026
·
6 min read
Press Releases
Medical Care Technologies Demonstrates Broad Monetization Power Across AI Vision, Software Development and Digital Platforms (OTC Pink:MDCE)
August 2, 2026
·
3 min read
Genetown
Magenta Therapeutics Adopts Limited Duration Stockholder Rights Plan
Magenta Therapeutics, Inc. announced that its Board of Directors has unanimously adopted a limited duration stockholder rights plan.
March 31, 2023
·
5 min read
1 of 40,693
Next
